Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Viscous Budesonide vs Elimination Diet in Pediatric EoE
NCT01821898Phase 2Terminated
- Sponsor
- Baylor College of Medicine
- Start
- Jul 2013
- Primary completion
- Sep 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of EPI-EE in eosinophilic esophagitis (EoE), sponsored by Baylor College of Medicine. Started Jul 2013; status: terminated.
02
Drugs
EPI-EE
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT01821898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01821898.